Skip to main content
. 2021 Sep 3;64(3):565–574. doi: 10.1007/s00234-021-02799-4

Table 2.

Treatment, time course, and outcomes in patients with anterior and posterior circulation occlusion

Characteristics Total Anterior circulation occlusion Posterior circulation occlusion p value
Intravenous rt-PA (%) 180 (51.0) 162 (51.6) 18 (46.2) 0.522
First-pass devices
Stent retriever (%) 101 (28.6) 90 (28.7) 11 (28.2) 0.952
Aspiration catheter (%) 123 (34.8) 110 (35.0) 13 (33.3) 0.834
Combined approach (%) 103 (29.2) 93 (29.6) 10 (25.6) 0.606
Other devices (%) 26 (7.4) 21 (6.7) 5 (12.8) 0.187
PTA (%) 46 (13.0) 41 (13.1) 5 (12.8) 0.967
Stent placement (%) 19 (5.4) 17 (5.4) 2 (5.1) 1.000
Medical therapy other than rt-PA (%) 35 (9.9) 34 10.8) 1 (2.6) 0.152
Time course
Onset-to-door time, median (IQR), min 112.5 (58.8–240.5) 112 (60–241) 117 (53–314) 0.888
Door-to-picture time, median (IQR), min 17 (12–25) 17 (12–24) 24 (16–36) 0.005*
Door-to-needle time, median (IQR), min 74 (61–89) 72 (61–85) 93 (83–123)  < 0.001*
Door-to-puncture time, median (IQR), min 69 (46–102) 65 (45–99) 99 (51–121) 0.018*
Picture to puncture time, median (IQR), min 56.5 (36–80.3) 52 (35–76.5) 77 (60–96) 0.001*
Puncture-to-reperfusion time, median (IQR), min 49 (31–74) 48 (31–74) 52 (37–77) 0.384
Door-to-reperfusion time, median (IQR), min 127 (93–165) 125 (90–156) 163 (121–203) 0.004*
Onset-to-reperfusion time, median (IQR), min 270 (195–376) 267 (191–370) 295 (231–442) 0.079
TICI 2B-3 reperfusion (%) 287 (81.3) 257 (81.8) 30 (76.9) 0.457
TICI 3 reperfusion (%) 160 (45.3) 141 (44.9) 19 (48.7) 0.652
First-pass TICI 2B-3 reperfusion (%) 157 (44.4) 137 (43.6) 20 (51.3) 0.364
Number of passes, median (IQR) 3 (2–4) 3 (2–4) 2 (2–3) 0.036*
Symptomatic complication
Ischemic complication (%) 2 (0.6) 2 (0.6) 0 (0) 1.000
Hemorrhagic complication (%) 20 (5.7) 19 (6.1) 1 (2.6) 0.711
Puncture related complication (%) 8 (2.3) 7 (2.2) 1 (2.6) 1.000
Hospitalization period (IQR), day 29 (18–41) 29.5 (18.3–41) 27 (12–39) 0.226
mRS at discharge 3 (2–5) 3 (2–5) 4 (2–5) 0.325
mRS ≤ 2 at discharge (%) 118 (33.4) 106 (33.8) 12 (30.8) 0.709
Mortality (%) 30 (8.5) 22 (7.0) 8 (20.5) 0.010*

*p < 0.05. †In cases that were not achieved successful reperfusion in the first pass

rt-PA recombinant tissue-type plasminogen activator, PTA percutaneous transluminal angioplasty, IQR interquartile range, TICI Thrombolysis in Cerebral Ischemia